litlas
ログインアカウント作成

Michael F. Press

1977–2025 年に発表

128
論文数
45,516
被引用数
89
h 指数
126
i10 指数

被引用数

Michael F. Press の年別被引用数1974 年: 被引用 1 件1976 年: 被引用 1 件1978 年: 被引用 1 件1979 年: 被引用 1 件1980 年: 被引用 1 件1982 年: 被引用 1 件1985 年: 被引用 4 件1986 年: 被引用 12 件1987 年: 被引用 15 件1988 年: 被引用 24 件1989 年: 被引用 18 件1990 年: 被引用 51 件1991 年: 被引用 64 件1992 年: 被引用 76 件1993 年: 被引用 60 件1994 年: 被引用 74 件1995 年: 被引用 82 件1996 年: 被引用 62 件1997 年: 被引用 100 件1998 年: 被引用 95 件1999 年: 被引用 132 件2000 年: 被引用 203 件2001 年: 被引用 220 件2002 年: 被引用 216 件2003 年: 被引用 217 件2004 年: 被引用 236 件2005 年: 被引用 257 件2006 年: 被引用 251 件2007 年: 被引用 307 件2008 年: 被引用 345 件2009 年: 被引用 382 件2010 年: 被引用 405 件2011 年: 被引用 367 件2012 年: 被引用 426 件2013 年: 被引用 425 件2014 年: 被引用 389 件2015 年: 被引用 352 件2016 年: 被引用 327 件2017 年: 被引用 331 件2018 年: 被引用 297 件2019 年: 被引用 913 件2020 年: 被引用 907 件2021 年: 被引用 948 件2022 年: 被引用 737 件2023 年: 被引用 609 件2024 年: 被引用 844 件2025 年: 被引用 407 件2026 年: 被引用 18 件1975 年は被引用が無いため表示していません1977 年は被引用が無いため表示していません1981 年は被引用が無いため表示していません1983〜1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,858 件、この内訳の 28.9%中国: 引用元論文 1,249 件、この内訳の 7.4%イギリス: 引用元論文 1,130 件、この内訳の 6.7%ドイツ: 引用元論文 799 件、この内訳の 4.7%イタリア: 引用元論文 791 件、この内訳の 4.7%カナダ: 引用元論文 667 件、この内訳の 4%フランス: 引用元論文 566 件、この内訳の 3.4%スペイン: 引用元論文 543 件、この内訳の 3.2%日本: 引用元論文 487 件、この内訳の 2.9%オーストラリア: 引用元論文 402 件、この内訳の 2.4%韓国: 引用元論文 398 件、この内訳の 2.4%スイス: 引用元論文 379 件、この内訳の 2.3%
0%28.9%その他 27%

機関

分野

  • Medicine57.3%
  • Biochemistry, Genetics and Molecular Biology33.2%
  • Immunology and Microbiology2.8%
  • Computer Science2.7%
  • Neuroscience0.8%
  • Materials Science0.7%
  • その他2.5%

トピック

  • HER2/EGFR in Cancer Research11%
  • Breast Cancer Treatment Studies6.3%
  • Monoclonal and Polyclonal Antibodies Research5%
  • Cancer Genomics and Diagnostics3.2%
  • Advanced Breast Cancer Therapies2.8%
  • Cancer Cells and Metastasis2%
  • その他69.7%

共著者

全論文

検索で開く
  1. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

    著者: Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison, Brittany Harvey, Pamela B. Mangu, John M.S. Bartlett, Michael Bilous, Ian O. Ellis, Patrick L. Fitzgibbons, Wedad Hanna, Robert B. Jenkins, Michael F. Press, Patricia A. Spears, Gail H. Vance, Giuseppe Viale, Lisa M. McShane, Mitch Dowsett - Archives of Pathology & Laboratory Medicine 2018 被引用: 2,454

  2. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

    著者: P. Tarantino, Giulia Viale, Michael F. Press, Xin Hu, Frédérique Penault‐Llorca, A. Bardia, Anna Batistatou, H.J. Burstein, L.A. Carey, Javier Cortés, C. Denkert, V. Diéras, William Jacot, A. Koutras, Alizée Lebeau, S. Loibl, Shanu Modi, M.F. Mosele, Elena Provenzano, Giancarlo Pruneri, Jorge S. Reis‐Filho, Federico Rojo, Roberto Salgado, P. Schmid, Stuart J. Schnitt, S.M. Tolaney, Dario Trapani, A. Vincent-Salomon, A.C. Wolff, George Pentheroudakis, Fabrice André, G. Curigliano - Annals of Oncology 2023 被引用: 299

  3. Adjuvant Trastuzumab in HER2-Positive Breast Cancer

    著者: Dennis J. Slamon, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, Miguel Martín, Michael F. Press, John R. Mackey, John A. Glaspy, Arlene Chan, Marek Pawlicki, Tamás Pintér, Vicente Valero, Mei-Ching Liu, Guido Sauter, Gϋnter von Minckwitz, F. Visco, Valerie Bée, Marc Buyse, Belguendouz Bendahmane, Isabelle Tabah-Fisch, Mary-Ann Lindsay, A. Riva, John Crown - New England Journal of Medicine 2011 被引用: 2,775

  4. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

    著者: Dennis J. Slamon, William Godolphin, Lovell A. Jones, John A. Holt, Steven Wong, Duane E. Keith, Wendy J. Levin, Susan G. Stuart, Judy Udove, Axel Ullrich, Michael F. Press - Science 1989 被引用: 6,863

  5. Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains

    著者: Nikhil Naik, Ali Madani, Andre Esteva, Nitish Shirish Keskar, Michael F. Press, Daniel Ruderman, David B. Agus, Richard Socher - Nature Communications 2020 被引用: 249

  6. A Big Bang model of human colorectal tumor growth

    著者: Andrea Sottoriva, Haeyoun Kang, Zhicheng Ma, Trevor A. Graham, Matthew P. Salomon, Junsong Zhao, Paul Marjoram, Kimberly D. Siegmund, Michael F. Press, Darryl Shibata, Christina Curtis - Nature Genetics 2015 被引用: 1,058

  7. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

    著者: Rosie Bradley, Jeremy Braybrooke, Richard J. Gray, Robert K. Hills, Zulian Liu, Richárd Pető, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn Taylor, Stewart Anderson, Richard D. Gelber, Luca Gianni, William Jacot, Heikki Joensuu, Alvaro Moreno‐Aspitia, Martine Piccart, Michael F. Press, Edward H. Romond, Dennis J. Slamon, Vera J. Suman, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Yaochen Wang, John Crown, Evandro de Azambuja, Suzette Delaloge, Helena Fung, Charles E. Geyer, M. Spielmann, Pinuccia Valagussa, Kathy S. Albain, Stewart Anderson, R. Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, Michael Gnant, Matthew Bidwell Goetz, Pam Goodwin, Pat Halpin-Murphy, Daniel Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori J. Pierce, Philip Poortmans, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Tanja Španić, Joseph A. Sparano, Guenther G. Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Timothy J. Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Kathleen I. Pritchard ほか 1 名 - The Lancet Oncology 2021 被引用: 348

  8. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

    著者: Jeremy Braybrooke, Rosie Bradley, Richard Gray, Robert K. Hills, Hongchao Pan, Richárd Pető, David Dodwell, Paul McGale, Carolyn Taylor, Tomohiko Aihara, Stewart Anderson, Joanne L. Blum, Fátima Cardoso, Xiaosong Chen, John Crown, Bent Ejlertsen, Thomas W. P. Friedl, Nadia Harbeck, Wolfgang Janni, Maj‐Britt Jensen, E. Mamounas, Kazutaka Narui, Ulrike Nitz, Larry Norton, Joyce O’Shaughnessy, Martine Piccart, Nicholas J. Robert, Zhi‐Ming Shao, Dennis Slamon, Joseph A. Sparano, Toru Watanabe, Greg Yothers, Ke‐Da Yu, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Lui, Zulian Lui, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Aman U. Buzdar, Vera J. Suman, Kelly K. Hunt, Robert Leonard, Janine Mansi, Catherine Delbaldo, Pascal Piedbois, Emmanuel Quinaux, Christian Fesl, Michael Gnant, Lidija Sölkner, Guenther G. Steger, Hans Petter Eikesdal, Per Eystein Lønning, Valerie Bée, Helena Fung, John R. Mackey, Miguel Martín, Michael F. Press, Evandro de Azambuja, Richard D. Gelber, Meredith M. Regan, Angelo Di Leo, Veerle Van Dooren, J.-M. Nogaret, John M.S. Bartlett, Bingshu E. Chen, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Kathleen I. Pritchard, Lois E. Shepherd, Donald A. Berry, Constance Cirrincione, Lawrence N. Shulman, Eric P. Winer, Rebecca Gelman, Jay R. Harris, Craig Henderson, Charles L. Shapiro, Peer Christiansen, Marianne Ewertz, Henning T. Mouridsen, Elise Van Leeuwen, Sabine C. Linn, Annelot G.J. van Rossum, Harm van Tinteren ほか 136 名 - The Lancet 2023 被引用: 189

  9. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

    著者: Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks, Mitch Dowsett, Lisa M. McShane, Kimberly H. Allison, D. Craig Allred, John M.S. Bartlett, Michael Bilous, Patrick L. Fitzgibbons, Wedad Hanna, Robert B. Jenkins, Pamela B. Mangu, Soonmyung Paik, Edith A. Perez, Michael F. Press, Patricia A. Spears, Gail H. Vance, Giuseppe Viale, Daniel F. Hayes - Archives of Pathology & Laboratory Medicine 2013 被引用: 4,061

  10. Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial

    著者: J. Randolph Hecht, Yung‐Jue Bang, Shukui Qin, Hyun Cheol Chung, Jianming Xu, Joon Oh Park, Krzysztof Jeziorski, Yaroslav Shparyk, Paulo M. Hoff, Alberto Sobrero, Pamela Salman, Jin Li, Светлана Проценко, Zev A. Wainberg, Marc Buyse, Karen Afenjar, Vincent Houé, Agathe Garcia, Tomomi Kaneko, Yingjie Huang, S. Khan‐Wasti, Sergio Santillana, Michael F. Press, Dennis J. Slamon - Journal of Clinical Oncology 2015 被引用: 621

  11. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

    著者: Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz, Karen L. Hagerty, D. Craig Allred, Richard J. Côté, Mitch Dowsett, Patrick L. Fitzgibbons, Wedad Hanna, Amy S. Langer, Lisa M. McShane, Soonmyung Paik, Mark D. Pegram, Edith A. Perez, Michael F. Press, Anthony Rhodes, Catharine M. Sturgeon, Sheila E. Taube, Raymond Tubbs, Gail H. Vance, Marc J. van de Vijver, Thomas M. Wheeler, Daniel F. Hayes - Archives of Pathology & Laboratory Medicine 2006 被引用: 4,475

  12. Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2− Breast Cancer

    著者: Sara A. Hurvitz, Miguel Martín, Michael F. Press, David Chan, María Fernandez-Abad, Edgar Petru, Regan Rostorfer, Valentina Guarneri, Chiun‐Sheng Huang, Susana Barriga, Sameera R. Wijayawardana, Manisha Brahmachary, Philip J. Ebert, Anwar Hossain, Jiangang Liu, Adam Abel, Amit Aggarwal, Valerie M. Jansen, Dennis J. Slamon - Clinical Cancer Research 2019 被引用: 220

  13. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

    著者: Charles L. Vogel, Melody Cobleigh, Debu Tripathy, John Gutheil, Lyndsay N. Harris, Louis Fehrenbacher, Dennis J. Slamon, Maureen Murphy, William Novotny, Michael Burchmore, Steven Shak, Stanford J. Stewart, Michael F. Press - Journal of Clinical Oncology 2002 被引用: 1,859

  14. Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers

    著者: Rémi Klotz, Amal Thomas, Teng Teng, Sung Min Han, Oihana Iriondo, Lin Li, Sara Restrepo-Vassalli, Alan Wang, Negeen Izadian, Matthew MacKay, Byoung-San Moon, Kevin J. Liu, Sathish Kumar Ganesan, Grace Lee, Diane S. Kang, Charlotte S. Walmsley, Christopher J. Pinto, Michael F. Press, Wange Lu, Janice Lu, Dejan Juric, Aditya Bardia, James Hicks, Bodour Salhia, Frank J. Attenello, Andrew D. Smith, Min Yu - Cancer Discovery 2019 被引用: 142

  15. Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer

    著者: Stephen Johnston, John Pippen, Xavier Pivot, Mikhail Lichinitser, Saeed Sadeghi, Véronique Dièras, Henry Gómez, Gilles Romieu, Alexey Manikhas, M. John Kennedy, Michael F. Press, J. Maltzman, Allison Florance, Lisa O’Rourke, Cristina Oliva, Steven Stein, Mark D. Pegram - Journal of Clinical Oncology 2009 被引用: 1,024

  16. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE

    著者: Stephen Johnston, Roberto Hegg, Seock‐Ah Im, In Hae Park, Olga Burdaeva, G. Kurteva, Michael F. Press, Sergei Tjulandin, Hiroji Iwata, Sérgio D. Simon, Sarah Kenny, Séverine Sarp, Miguel Izquierdo, Lisa S. Williams, William J. Gradishar - Journal of Clinical Oncology 2020 被引用: 126

  17. Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE)

    著者: Sanne Lysbet de Haas, Dennis J. Slamon, Miguel Martín, Michael F. Press, Gail D. Lewis Phillips, Chiara Lambertini, Aleix Prat, Vanesa López-Valverde, Thomas Boulet, Sara A. Hurvitz - Breast Cancer Research 2023 被引用: 43

  18. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: ALTERNATIVE

    著者: Stephen Johnston, Roberto Hegg, Seock‐Ah Im, In Hae Park, Olga Burdaeva, G. Kurteva, Michael F. Press, Sergei Tjulandin, Hiroji Iwata, Sérgio D. Simon, Sarah Kenny, Séverine Sarp, Miguel Izquierdo, Lisa S. Williams, William J. Gradishar - Journal of Clinical Oncology 2017 被引用: 166

  19. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

    著者: Michael F. Press, Carlos Cordon‐Cardo, Dennis J. Slamon - 1990 被引用: 648

  20. Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors

    著者: Martina S.J. McDermott, Neil A. O’Brien, Benjamin Hoffstrom, KeWei Gong, Ming Lu, Jun Zhang, Tong Luo, Min Liang, Weiping Jia, Jenny J. Hong, Kevin Chau, Simon Davenport, Bin Xie, Michael F. Press, Richard Panayiotou, Abram Handly‐Santana, Joan S. Brugge, Leonard Presta, John A. Glaspy, Dennis J. Slamon - Clinical Cancer Research 2023 被引用: 53

  21. A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System

    著者: Evan N. Cohen, Gitanjali Jayachandran, Richard G. Moore, Massimo Cristofanilli, Julie E. Lang, Joseph D. Khoury, Michael F. Press, Kyu Kwang Kim, Negar Khazan, Qiang Zhang, Youbin Zhang, Pushpinder Kaur, Roberta Guzman, Michael Craig Miller, James M. Reuben, Naoto T. Ueno - Cancers 2022 被引用: 58

  22. Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry

    著者: Zhaohui Du, Guimin Gao, Babatunde Adedokun, Thomas U. Ahearn, Kathryn L. Lunetta, Gary Zirpoli, Melissa A. Troester, Edward Ruiz-Narváez, Stephen A. Haddad, Parichoy PalChoudhury, Jonine D. Figueroa, Esther M. John, Leslie Bernstein, Wei Zheng, Jennifer J. Hu, Regina G. Ziegler, Sarah J. Nyante, Elisa V. Bandera, Sue A. Ingles, Nicholas Mancuso, Michael F. Press, Sandra L. Deming, Jorge L. Rodriguez‐Gil, Song Yao, Temidayo O. Ogundiran, Oladosu Ojengbe, Manjeet K. Bolla, Joe Dennis, Alison M. Dunning, Douglas F. Easton, Kyriaki Michailidou, Paul D.P. Pharoah, Dale P. Sandler, Jack A. Taylor, Qin Wang, Clarice R. Weinberg, Cari M. Kitahara, William J. Blot, Katherine L. Nathanson, Anselm Hennis, Barbara Nemesure, Stefan Ambs, Lara Sucheston‐Campbell, Jeannette T. Bensen, Stephen J. Chanock, Andrew F. Olshan, Christine B. Ambrosone, Olufunmilayo I. Olopade, Joel Yarney, Baffour Awuah, Beatrice Wiafe‐Addai, David V. Conti, the GBHS Study Team, Julie R. Palmer, Montserrat García‐Closas, Dezheng Huo, Christopher A. Haiman - JNCI Journal of the National Cancer Institute 2021 被引用: 76

  23. Abstract GS2-03: GS2-03 TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer

    著者: Aditya Bardia, Sara A. Hurvitz, Michael F. Press, Lisa S. Wang, Nicholas P. McAndrew, David W. Chan, Vu Phan, Deborah Villa, Merry Tetef, Erin Chamberlain, Nihal Abdulla, Thomas J. Lomis, Laura M. Spring, Steven Applebaum, Shaker R. Dakhil, Brian DiCarlo, David D. Kim, Evangelia Kirimis, William Lawler, Aashini K. Master, Kelly McCann, Edwin Hayashi, Christine Kivork, James Chauv - Cancer Research 2023 被引用: 31

  24. Genome-wide association analyses of breast cancer in women of African ancestry identify new susceptibility loci and improve risk prediction

    著者: Guochong Jia, Jie Ping, Xingyi Guo, Yaohua Yang, Ran Tao, Bingshan Li, Stefan Ambs, Mollie E. Barnard, Yu Chen, Montserrat García‐Closas, Jian Gu, Jennifer J. Hu, Dezheng Huo, Esther M. John, Christopher I. Li, James Li, Katherine L. Nathanson, Barbara Nemesure, Olufunmilayo I. Olopade, Tuya Pal, Michael F. Press, Maureen Sanderson, Dale P. Sandler, Xiao‐Ou Shu, Melissa A. Troester, Song Yao, Prisca Olabisi Adejumo, Thomas U. Ahearn, Abenaa M. Brewster, Anselm Hennis, Timothy Makumbi, Paul Ndom, Katie M. O’Brien, Andrew F. Olshan, Mojisola Oluwasanu, Sonya Reid, Eboneé N. Butler, Maosheng Huang, Atara Ntekim, Huijun Qian, Haoyu Zhang, Christine B. Ambrosone, Qiuyin Cai, Jirong Long, Julie R. Palmer, Christopher A. Haiman, Wei Zheng - Nature Genetics 2024 被引用: 56